Relaxin and HFpEF: unveiling a new contributor to personalized medicine?
Aims Although Heart Failure with Preserved Ejection Fraction (HFpEF) is a growing health problem, there are still significant caveats on the understanding of its pathophysiology, diagnosis and treatment. We aimed to evaluate the role of Relaxin-2 (RLX2) circulating levels on the diagnosis of chronic...
| Autor principal: | |
|---|---|
| Formato: | masterThesis |
| Idioma: | eng |
| Publicado em: |
2022
|
| Assuntos: | |
| Texto completo: | https://hdl.handle.net/10216/142249 |
| País: | Portugal |
| Oai: | oai:repositorio-aberto.up.pt:10216/142249 |